Highlight
It is time to address ambulatory central venous line infections in pediatric hematology/oncology patients
First published: 12 September 2016
No abstract is available for this article.
REFERENCES
- 1Bundy DG, Gaur AH, Billett AL, et al. Preventing CLABSIs among pediatric hematology/oncology inpatients: national collaborative results. Pediatrics. 2014; 134(6): e1678–e1685.
- 2Hord JD, Lawlor J, Werner E, et al. Central line associated blood stream infections in pediatric hematology/oncology patients with different types of central lines. Pediatr Blood Cancer. 2016; 63(9): 1603–1607.
- 3Quiles CIW, Gottsch S, Thakrar U, Fraile B, Billett AL. Health care institutional charges associated with ambulatory bloodstream infections in pediatric oncology and stem cell transplant patients. Pediatr Blood Cancer. 2017; 64(2): 324–329.
- 4Miller MR, Niedner MF, Huskins WC, et al. Reducing PICU central line-associated bloodstream infections: 3-year results. Pediatrics. 2011; 128(5): e1077–e1083.
- 5Rinke ML, Bundy DG, Chen AR, et al. Central line maintenance bundles and CLABSIs in ambulatory oncology patients. Pediatrics. 2013; 132(5): e1403–e1412.
- 6Neu AM, Richardson T, Lawlor J, et al. Implementation of standardized follow-up care significantly reduces peritonitis in children on chronic peritoneal dialysis. Kidney Int. 2016; 89(6): 1346–1354.
- 7Peasah SK, McKay NL, Harman JS, Al-Amin M, Cook RL. Medicare non-payment of hospital-acquired infections: infection rates three years post implementation. Medicare Medicaid Res Rev. 2013; 3(3): E1–E13.
- 8Olmstead MG, Geisen E, Murphy J, Bell D, Stanley M. Methodology. U.S. News and World Report. Best Children's Hospitals 2016–20172016 [cited 2016 July 25]. Available from: https://www.rti.org/sites/default/files/resources/bch%202016-17%20methodology%20report%20final%20_june27.pdf.
